New Insights into Anticarcinogenic Properties of Adiponectin: A Potential Therapeutic Approach in Breast Cancer?

被引：23
作者：
Delort, Laetitia [1 ,2 ]
Jarde, Thierry [1 ,2 ]
Dubois, Virginie [1 ,2 ]
Vasson, Marie-Paule [1 ,2 ,3 ]
Caldefie-Chezet, Florence [1 ,2 ]
机构：
[1] Univ Auvergne, Clermont Univ, UFR Pharm, Lab SVFp, F-63000 Clermont Ferrand, France
[2] INRA, ECRIN, CRNH Auvergne, UMR 1019, F-63000 Clermont Ferrand, France
[3] Ctr Jean Perrin, Unite Nutr, F-63003 Clermont Ferrand, France
来源：
ADIPONECTIN | 2012年 / 90卷
关键词：
ACTIVATED RECEPTOR-GAMMA; PLASMA ADIPONECTIN; SERUM ADIPONECTIN; PPAR-GAMMA; CELL-PROLIFERATION; IN-VITRO; BINDING PROTEIN; ADIPOSE-TISSUE; OBESE WOMEN; GROWTH;
D O I：
10.1016/B978-0-12-398313-8.00015-4
中图分类号：
Q5 [生物化学]; Q7 [分子生物学];
学科分类号：
071010 ; 081704 ;
摘要：
Obesity is a recognized breast cancer risk factor in postmenopausal women. A recent hypothesis suggests a major role for adipose tissue in carcinogenesis. During many years, the adipose tissue was only considered as a fat storage of energy. This tissue is now described as an endocrine organ secreting a large range of molecules called adipokines. Among these adipokines, adiponectin may play a major role in breast cancer. Plasma adiponectin levels were found to be decreased in cases of breast cancer and in obese patients. Adiponectin may act directly on breast cancer cells by inhibiting proliferation and angiogenesis or by stimulating apoptosis. Increasing adiponectin levels may be of major importance in the prevention and/or the treatment of breast cancer. This therapeutic approach may be of particular significance for obese patients. The beneficial effects of adiponectin and its possible therapeutic applications will be discussed in this review.
引用
收藏
页码：397 / 417
页数：21
相关论文
共 69 条
  • [1] Combined effects of obesity and type 2 diabetes contribute to increased breast cancer risk in premenopausal women
    Alokail, Majed S.
    Al-Daghri, Nasser M.
    Al-Attas, Omar S.
    Hussain, Tajamul
    [J]. CARDIOVASCULAR DIABETOLOGY, 2009, 8
  • [2] Anti proliferative effect of adiponectin on MCF7 breast cancer cells: a potential hormonal link between obesity and cancer
    Arditi, J. D.
    Venihaki, M.
    Karalis, K. P.
    Chrousos, G. P.
    [J]. HORMONE AND METABOLIC RESEARCH, 2007, 39 (01) : 9 - 13
  • [3] Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell
    Arita, Y
    Kihara, S
    Ouchi, N
    Maeda, K
    Kuriyama, H
    Okamoto, Y
    Kumada, M
    Hotta, K
    Nishida, M
    Takahashi, M
    Nakamura, T
    Shimomura, I
    Muraguchi, M
    Ohmoto, Y
    Funahashi, T
    Matsuzawa, Y
    [J]. CIRCULATION, 2002, 105 (24) : 2893 - 2898
  • [4] Adiponectin in relation to malignancies: a review of existing basic research and clinical evidenced
    Barb, Diana
    Williams, Catherine J.
    Neuwirth, Anke K.
    Mantzoros, Christos S.
    [J]. AMERICAN JOURNAL OF CLINICAL NUTRITION, 2007, 86 (03) : 858S - 866S
  • [5] Gender differences of adiponectin levels develop during the progression of puberty and are related to serum androgen levels
    Böttner, A
    Kratzsch, J
    Müller, G
    Kapellen, TM
    Blüher, S
    Keller, E
    Blüher, M
    Kiess, W
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (08) : 4053 - 4061
  • [6] Use of the peroxisome proliferator-activated receptor (PPAR) γ ligand troglitazone as treatment for refractory breast cancer:: a phase II study
    Burstein, HJ
    Demetri, GD
    Mueller, E
    Sarraf, P
    Spiegelman, BM
    Winer, EP
    [J]. BREAST CANCER RESEARCH AND TREATMENT, 2003, 79 (03) : 391 - 397
  • [7] Calle EE, 1996, LANCET, V347, P1713, DOI 10.1016/S0140-6736(96)90806-5
  • [8] Obesity and cancer
    Calle, EE
    Thun, MJ
    [J]. ONCOGENE, 2004, 23 (38) : 6365 - 6378
  • [9] Induction of adipocyte complement-related protein of 30 kilodaltons by PPARγ agonists:: A potential mechanism of insulin sensitization
    Combs, TP
    Wagner, JA
    Berger, J
    Doebber, T
    Wang, WJ
    Zhang, BB
    Tanen, M
    Berg, AH
    O'Rahilly, S
    Savage, DB
    Chatterjee, K
    Weiss, S
    Larson, PJ
    Gottesdiener, KM
    Gertz, BJ
    Charron, MJ
    Scherer, PE
    Moller, DE
    [J]. ENDOCRINOLOGY, 2002, 143 (03) : 998 - 1007
  • [10] Adiponectin mediates antiproliferative and apoptotic responses in human MCF7 breast cancer cells
    Dieudonne, Marie-Noelle
    Bussiere, Marianne
    Dos Santos, Esther
    Leneveu, Marie-Christine
    Giudicelli, Yves
    Pecquery, Rene
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 345 (01) : 271 - 279
1234567